Cargando…
Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
Prostate cancer (PCa) is the second most common cancer in men. As well in many other human cancers, inflammation and immune suppression have an important role in their development. We briefly describe the host components that interact with the tumor to generate an immune suppressive environment invo...
Autores principales: | Silvestri, Ida, Cattarino, Susanna, Aglianò, Anna Maria, Collalti, Giulia, Sciarra, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486485/ https://www.ncbi.nlm.nih.gov/pubmed/26161414 http://dx.doi.org/10.1155/2015/794968 |
Ejemplares similares
-
A Perspective of Immunotherapy for Prostate Cancer
por: Silvestri, Ida, et al.
Publicado: (2016) -
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
por: Silvestri, Ida, et al.
Publicado: (2013) -
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
por: Sciarra, Alessandro, et al.
Publicado: (2016) -
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
por: Sciarra, Alessandro, et al.
Publicado: (2023) -
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review
por: Sciarra, Alessandro, et al.
Publicado: (2019)